Insider Transactions in Q1 2025 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 29
2025
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,230
-7.43%
|
$146,760
$12.54 P/Share
|
Jan 01
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-0.39%
|
$5,421
$13.71 P/Share
|